Literature DB >> 22088544

Genotype and allele frequencies of heme oxygenase-1 promoter region in a Greek cohort.

Eleni P Katana1, Lemonia G Skoura, Zacharias G Scouras, Michail A Daniilidis.   

Abstract

BACKGROUND: Heme oxygenase-1 (HO-1) is an enzyme, which catabolizes heme into carbon monoxide, biliverdin and free iron. The induction of this enzyme is an important cytoprotective mechanism, which occurs as an adaptive and beneficial response to a wide variety of oxidant stimuli. HO-1 inducibility is mainly modulated by a (GT)(n) polymorphism in the promoter region, and has been shown that short (S) repeats are associated with greater up-regulation of HO-1, compared with long (L) repeats.
METHODS: In the present study, 250 healthy Greek individuals have been screened in order to estimate the frequencies of (GT)(n) alleles in the HO-1 gene.
RESULTS: Nineteen different alleles, ranging from 17 to 39 repeats, with (GT)(23) and (GT)(30) being the most common ones, were identified.
CONCLUSION: The possible role of this polymorphism in disease states is discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22088544

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  2 in total

1.  Association of HMOX1 and NQO1 Polymorphisms with Metabolic Syndrome Components.

Authors:  Angélica Martínez-Hernández; Emilio J Córdova; Oscar Rosillo-Salazar; Humberto García-Ortíz; Cecilia Contreras-Cubas; Sergio Islas-Andrade; Cristina Revilla-Monsalve; Consuelo Salas-Labadía; Lorena Orozco
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

2.  Polymorphisms in the Haem Oxygenase-1 promoter are not associated with severity of Plasmodium falciparum malaria in Ghanaian children.

Authors:  Helle H Hansson; Lasse Maretty; Christina Balle; Bamenla Q Goka; Elisa Luzon; Francis N Nkrumah; Mette L Schousboe; Onike P Rodrigues; Ib Christian Bygbjerg; Jørgen A L Kurtzhals; Michael Alifrangis; Casper Hempel
Journal:  Malar J       Date:  2015-04-11       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.